Biomarkers of the Severity of Honeybee Sting Reactions and the Severity and Threshold of Systemic Adverse Events During Immunotherapy
Authors:
- 1 August 2021
- journal article
- research article
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 9 (8) , 3157-3163.e5
Abstract
No abstract availableKeywords
Funding Information
- The Slovenian Research and Innovation Agency (J3-6787, P3-0360)
This publication has 53 references indexed in Scilit:
- Anaphylaxis caused by Hymenoptera stings: from epidemiology to treatmentAllergy, 2011
- Three Days Rush Venom Immunotherapy in Bee Allergy: Safe, Inexpensive and Instantaneously EffectiveInternational Archives of Allergy and Immunology, 2011
- Benefit of the basophil activation test in deciding when to reintroduce cow’s milk in allergic childrenAllergy, 2010
- Mastocytosis and Hymenoptera venom allergyCurrent Opinion in Allergy and Clinical Immunology, 2006
- Multicenter study of emergency department visits for insect sting allergiesJournal of Allergy and Clinical Immunology, 2005
- Rush venom immunotherapy in patients experiencing recurrent systemic reactions to conventional venom immunotherapyAnnals of Allergy, Asthma & Immunology, 2003
- Side‐effects of insect venom immunotherapy:results from an EAACI multicenter studyAllergy, 2000
- Insect-sting challenge in 324 subjects with a previous anaphylactic reaction: Current criteria for insect-venom hypersensitivity do not predict the occurrence and the severity of anaphylaxisJournal of Allergy and Clinical Immunology, 1994
- The Hymenoptera venom study III: Safety of venom immunotherapyJournal of Allergy and Clinical Immunology, 1990
- INCIDENCE AND SEVERITY OF ANAPHYLACTOID REACTIONS TO COLLOID VOLUME SUBSTITUTESThe Lancet, 1977